for the latest info, visit https://www.ascpskincare.com/updates/blog-posts/coronavirus-and-your-practice 27
Consider Cytokine Storm Syndromes and
Immunosuppression," T he Lancet 395, no. 10229
(March 2020): 1033–34, https://doi.org/10.1016/
S0140-6736(20)30628-0. Note that both sources
are in the form of peer-reviewed correspondence
reflecting the ongoing developments and
uncertainty within the medical community.
16. Mary Van Beusekom, "Study: COVID-19 May
Spread in Several Different Ways," CIDRA P
News, March 2020, w w w.cidrap.umn.edu/
news-perspective/2020/03/study-covid-
19-may-spread-several-different-ways.
17. Wenling Wang et al., "Detection of SARS-
CoV-2 in Different Types of Clinical Specimens,"
JA MA , March 2020, https://doi.org/10.1001/
jama.2020.3786; Neeltje van Doremalen et
al., "Aerosol and Surface Stability of SARS-
CoV-2 as Compared with SARS CoV-1," T he
New England Journal of Medicine, March 2020,
https://doi.org/10.1056/NEJMc2004973.
18. American National Red Cross, "What to Know
about the Coronavirus and Blood Donation,"
2020, w w w.redcrossblood.org/donate-blood/dlp/
coronavirus--covid-19--and-blood-donation.html.
19. Jian Zhao et al., "Relationship Between the ABO
Blood Group and the COVID-19 Susceptibility,"
MedRxiv, preprint accessed March 2020, https://
doi.org/10.1101/2020.03.11.20031096.
20. Worldwide ABO Distribution is: O+: 38.67%; A+:
27.42%; B+ 22.02%; AB+: 5.88%, with the remainder
made up of the -Rh blood types. In China there are
several different ethnic groups (Canton, Ningbo,
Yangzhou, Peking, Han) with considerable variance
between the distributions; for example among
the "Peking" ethnic group, B is more common
than O or A. This is due to genetic variance.
Therefore, ethnic group information for this
sample is actually quite important. Laura Clark,
"World Population by Percentage of Blood Types,"
WorldAtlas, July 2019, w w w.worldatlas.com/
articles/what-are-the-different-blood-types.html.
21. David S. Jones, "History in a Crisis—Lessons
for Covid-19," The New England Journal of
Medicine, March 2020, https://doi.org/10.1056/
NEJMp2004361; Wendy E. Parmet and Michael
S. Sinha, "Covid-19—The Law and Limits of
Quarantine," The New England Journal of
Medicine, March 2020, https://doi.org/10.1056/
NEJMp2004211; Lawrence O. Gostin and James
G. Hodge Jr., "US Emergency Legal Responses to
Novel Coronavirus: Balancing Public Health and
Civil Liberties," JAMA 323, no. 12 (February 2020):
1131–32, https://doi.org/10.1001/jama.2020.2025.
22. Eric Martin and Bloomberg, "Coronavirus
Economic Impact 'Will be Severe,' at Least as Bad
as Great Depression, says IMF," Fortune, March
2020, w w w.fortune.com/2020/03/23/coronavirus-
economic-impact-predictions-great-recession-
2020-markets-imf; Lora Jones, David Brown,
and Daniele Palumbo, "Coronavirus: A Visual
Guide to the Economic Impact," BBC News, March
2020, w w w.bbc.com/news/ business-51706225;
Politico Magazine staff, "Coronavirus Will
Change the World Permanently. Here's How,"
Politico, March 2020, w w w.politico.com/news/
magazine/2020/03/19/coronavirus-effect-
economy-life-society-analysis-covid-135579;
Johann Fortwengel, "Coronavirus: Three Ways the
Crisis May Permanently Change Our Lives," The
Conversation, March 2020, w w w.theconversation.
com/coronavirus-three-ways-the-crisis-may-
permanently-change-our-lives-133954.
23. Katie Pearce, "SNF Agora Institute Discussion
Series Explores Policies, Politics of the Pandemic,"
Johns Hopkins Hub, March 2020, https://hub.
jhu.edu/2020/03/24/agora-coronavirus-series.
24. Hassan K. Siddiqi and Mandeep R.
Mehra, "COVID-19 Illness in Native and
Immunosuppressed States: A Clinical-Therapeutic
Staging Proposal," The Journal of Heart and Lung
Transplantation, preprint accessed March 2020,
https://doi.org/10.1016/j.healun.2020.03.012; Lisa
Rosenbaum, "Facing Covid-19 in Italy—Ethics,
Logistics, and Therapeutics on the Epidemic's
Front Line," The New England Journal of
Medicine, March 2020, https://doi.org/10.1056/
NEJMp2005492; Robert D. Truog, Christine
Mitchell, and George Q. Daley, "The Toughest
Triage—Allocating Ventilators in a Pandemic,"
The New England Journal of Medicine, March
2020, https://doi.org/10.1056/NEJMp2005689;
Ezekiel J. Emanuel et al., "Fair Allocation of Scarce
Medical Resources in the Time of Covid-19," The
New England Journal of Medicine, March 2020,
https://doi.org/10.1056/NEJMsb2005114.
25. Jia Liu et al., "Hydroxychloroquine, a Less
Toxic Derivative of Chloroquine is Effective
in Inhibiting SARS-CoV-2 Infection In Vitro,"
Cell Discovery 6, no. 16 (March 2020), https://
doi.org/10.1038/s41421-020-0156-0.
26. Phillippe Colson et al., "Chloroquine and
Hydroxychloroquine as Available Weapons to Fight
COVID-19," International Journal of Antimicrobial
Agents, preprint accessed March 2020, https://
doi.org/10.1016/j.ijantimicag.2020.105932;
Phillippe Gautret et al., "Hydroxychloroquine
and Azithromycin as a Treatment of COVID-19:
Results of an Open-Label Non-Randomized Clinical
Trial," International Journal of Antimicrobial
Agents, preprint accessed March 2020, https://
doi.org/10.1016/j.ijantimicag.2020.105949; Chen
Jun et al., "A Pilot Study of Hydroxychloroquine in
Treatment of Patients with Common Coronavirus
Disease-19 (COVID-19)," Journal of Zhejiang
University, 49, no. 1 (March 2020), https://doi.
org/10.3785/j.issn.1008-9292.2020.03.03.
27. Bin Cao et al., "A Trial of Lopinavir-Ritonavir
in Adults Hospitalized with Severe Covid-19,"
The New England Journal of Medicine, March
2020, https://doi.org/10.1056/NEJMoa2001282.
28. Jeanna Bryner, "Flu Drug Used in Japan
Shows Promise in Treating COVID-19,"
Livescience, w w w.livescience.com/flu-
drug-could-treat-coronavirus.html.
29. Chang Chen et al., "Favipiravir Versus Arbidol for
COVID-19: A Randomised Clinical Trial, MedRxiv,
preprint accessed March 2020, https://doi.org
/10.1101/2020.03.17.20037432; Qingxian Cai et
al., "Experimental Treatment with Favipiravir
for COVID-19: An Open-Label Control Study,"
Engineering, preprint accessed March 2020,
https://doi.org/10.1016/j.eng.2020.03.007;
Liying Dong, Sasha Hu, and Jianjun Go,
"Discovering Drugs to Treat Coronavirus
Disease 2019 (COVID-19)," Drug Discoveries
and Therapeutics 14, no. 1(March 2020): 58–60,
https://doi.org/10.5582/ddt.2020.01012.
30. Sandro G. Viveiros Rosa and Wilson C. Santos,
"Clinical Trials on Drug Repositioning For
COVID-19 Treatment," Pan American Journal
of Public Health 2020, no. 44 (March 2020):
e40, https://doi.org/10.26633/RPSP.2020.40.
31. International Committee of Medical Journal
Editors, "Recommendations for the Conduct,
Reporting, Editing, and Publication of Scholarly
Work in Medical Journals," ICMJE, December 2019,
w w w.icmje.org/icmje-recommendations.pdf.
32. Alonso Soto, "Nigeria Has Chloroquine
Poisonings After Trump Praised Drug," Bloomberg,
March 2020, w w w.bloomberg.com/news/
articles/2020-03-21/nigeria-reports-chloroquine-
poisonings-after-trump-praised-drug; ABC News,
"Valley Man Dies, Wife Hospitalized after Taking
Chemicals to Protect Them from Coronavirus,"
ABC News, March 23, 2020, w w w.abc15.com/news/
state/valley-man-dies-wife-hospitalized-after-
taking-chemicals-to-protect-from-coronavirus.
33. Adam Rogers, "Blood From COVID-19 Survivors
May Point the Way to a Cure," Wired, March 24,
2020; Arturo Casadevall and Liise-anne Pirofski,
"The Convalescent Sera Option for Containing
COVID-19," The Journal of Clinical Investigation,
March 2020, https://doi.org/10.1172/JCI138003.
34. Kristian G. Andersen et al., "The Proximal Origin
of SARS-CoV-2," Nature Medicine, March 2020,
https://doi.org/10.1038/s41591-020-0820-9.
35. Vineet D Menachery et al., "A SARS-Like
Cluster of Circulating Bat Coronaviruses
Shows Potential for Human Emergence,"
Nature Medicine 2015, no. 21 (March 2020):
1508–13, https://doi.org/10.1038/nm.3985.
36. Springer Nature Limited, "Content Types," Nature
(2020), w w w.nature.com/nm/about/content.